2024 annual financial data
SAB Biotherapeutics 2024 Financial results
Direct answer
Revenue was 1,322,410 USD.
Operating income was -42,910,520 USD and net income was -34,105,309 USD.
Operating cash flow was -34,292,009 USD.
Get free SAB Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,322,410 USD
- Operating income
- -42,910,520 USD
- Net income
- -34,105,309 USD
- Operating cash flow
- -34,292,009 USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all SAB Biotherapeutics financial years